Jun Chen

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 13

Top Topics

Sentinel Lymph Node

Top Venues

Nature computational science

Bioinformatics (Oxford, England)

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Lu Yang, Pei Wang, Jun Chen
2dGBH: Two-dimensional group Benjamini-Hochberg procedure for false discovery rate control in two-way multiple testing of genomic data. Bioinformatics (Oxford, England) 40 (2) (2024)
Tina J Hieken, Garth D Nelson, Thomas J Flotte, Eric P Grewal, Jun Chen, Robert R McWilliams, Lisa A Kottschade, Lu Yang, Evidio Domingo-Musibay, Roxana S Dronca, Yiyi Yan, Svetomir N Markovic, Anastasios Dimou, Heather N Montane, Courtney L Erskine, Mara A Piltin, Daniel L Price, Samir S Khariwala, Jane Yuet Ching Hui, Carrie A Strand, Susan M Harrington, Vera J Suman, Haidong Dong, Matthew S Block
Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for high-risk operable Stage III melanoma: the Phase II NeoACTIVATE trial. Nature communications 15 (1) (2024)
Lu Yang, Pei Wang, Jun Chen
2dGBH: Two-dimensional group Benjamini-Hochberg procedure for false discovery rate control in two-way multiple testing of genomic data. Bioinformatics (Oxford, England) 40 (2) (2024)
Lu Yang, Pei Wang, Jun Chen
2dGBH: Two-dimensional group Benjamini-Hochberg procedure for false discovery rate control in two-way multiple testing of genomic data. Bioinformatics (Oxford, England) 40 (2) (2024)
Tina J Hieken, Garth D Nelson, Thomas J Flotte, Eric P Grewal, Jun Chen, Robert R McWilliams, Lisa A Kottschade, Lu Yang, Evidio Domingo-Musibay, Roxana S Dronca, Yiyi Yan, Svetomir N Markovic, Anastasios Dimou, Heather N Montane, Courtney L Erskine, Mara A Piltin, Daniel L Price, Samir S Khariwala, Jane Yuet Ching Hui, Carrie A Strand, Susan M Harrington, Vera J Suman, Haidong Dong, Matthew S Block
Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for high-risk operable Stage III melanoma: the Phase II NeoACTIVATE trial. Nature communications 15 (1) (2024)
Hanxuan Ye, Xianyang Zhang, Chen Wang, Ellen L Goode, Jun Chen
Batch-effect correction with sample remeasurement in highly confounded case-control studies. Nature computational science 3 (8) (2023)
Priscila Santiago, Kevin P Quinn, Jun Chen, Jessica J Friton, Chad R Rypstra, Purna C Kashyap, Laura E Raffals
Altered Bile Acid and Pouch Microbiota Composition in Patients With Chronic Pouchitis. Inflammatory bowel diseases (2023)
Hanxuan Ye, Xianyang Zhang, Chen Wang, Ellen L Goode, Jun Chen
Batch-effect correction with sample remeasurement in highly confounded case-control studies. Nature computational science 3 (8) (2023)
Hanxuan Ye, Xianyang Zhang, Chen Wang, Ellen L Goode, Jun Chen
Batch-effect correction with sample remeasurement in highly confounded case-control studies. Nature computational science 3 (8) (2023)
Hanxuan Ye, Xianyang Zhang, Chen Wang, Ellen L Goode, Jun Chen
Batch-effect correction with sample remeasurement in highly confounded case-control studies. Nature computational science 3 (8) (2023)
Jun Chen, Xianyang Zhang
dICC: distance-based intraclass correlation coefficient for metagenomic reproducibility studies. Bioinformatics (Oxford, England) 38 (21) (2022)
Huy Quang Quach, Jun Chen, Jonathon M Monroe, Tamar Ratishvili, Nathaniel D Warner, Diane E Grill, Iana H Haralambieva, Inna G Ovsyannikova, Gregory A Poland, Richard B Kennedy
The influence of sex, BMI, and age on cellular and humoral immune responses against measles after a 3rd dose of MMR vaccine. The Journal of infectious diseases (2022)
Lu Yang, Jun Chen
A comprehensive evaluation of microbial differential abundance analysis methods: current status and potential solutions. Microbiome 10 (1) (2022)